glp 1 agonist oral New GLP-1 Guidelines for Type 2 Diabetes in 2025 Oral GLP-1 receptor agonists: competition

Wegovy (semaglutide) is a prescription glucagon-like peptide-1 (GLP-1) medication approved by the Food and Drug Administration (FDA) to reduce excess body weight and maintain weight reduction in people ages 12 and older with a diagnosis of obesity or in adults who are overweight with a weight-related health condition

That is their primary mechanism for weight loss

[Google Scholar] 11.Blood pressure-lowering effect of newer antihyperglycemic agents (SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors) Liakos CI, Papadopoulos DP, Sanidas EA, et al

& Larsen, M

But I do think there are some potential benefits

As more patients and healthcare providers seek effective diabetes management solutions with minimal side effects, demand for GLP-1 receptor agonists is set to surge